Search documents
Arteris Closes Acquisition of Cycuity
Globenewswire· 2026-01-14 21:05
Arteris adds to product portfolio to address secure data movement from AI data centers to edge devices with leading semiconductor cybersecurity assurance technology.CAMPBELL, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it has closed its previously announced acquisition of Cycuity, Inc., a leading provider and domain expert of semiconductor cybersecurity assurance technology. Semico ...
RF Industries Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Accessnewswire· 2026-01-14 21:05
SAN DIEGO, CA / ACCESS Newswire / January 14, 2026 / RF Industries, Ltd, (NASDAQ:RFIL), a national manufacturer and marketer of interconnect products and systems, today announced financial results for the fourth quarter and fiscal year ended October 31, 2025.Fourth Quarter Fiscal 2025 Highlights and Operating Results:Net sales were $22.7 million, an increase of 23% from $18.5 million year-over-year and an increase of 15% from $19.8 million in the third quarter of fiscal 2025.Backlog of $15.5 million at q ...
American Vanguard Corporation Announces Executive Appointment and Relocation of Global Headquarters
Accessnewswire· 2026-01-14 21:05
NEWPORT BEACH, CA / ACCESS Newswire / January 14, 2026 / American Vanguard Corporation (NYSE:AVD) has announced, the following change to its executive management team. Mike DiPaola has been appointed Chief Commercial Officer. In this role, he will focus on North American commercial strategy and execution. Mr. DiPaola joined American Vanguard in February 2025, and previously served as Senior Vice President of Strategy, Marketing, & R&D.Dak Kaye, III, Chief Executive Officer of American Vanguard stated, "M ...
FIRST FINANCIAL BANK ANNOUNCES PROMOTIONS AS PART OF ITS CONTINUED SUCCESSION PLANNING
Prnewswire· 2026-01-14 21:05
ABILENE, Texas, Jan. 14, 2026 /PRNewswire/ -- The Board of Directors of First Financial Bank (the "Bank"), subsidiary of First Financial Bankshares, Inc. (NASDAQ: FFIN) (the "Company"), has announced the following promotions for the Bank. These promotions are part of the Company's ongoing management succession, which management and the board have been working on for several years. James Alexander has been promoted to Executive Vice President, Head of Commercial Banking for the Bank, a position most recentl ...
JFrog Announces Timing of Fourth Quarter and Fiscal 2025 Financial Results
Businesswire· 2026-01-14 21:05
Date: Thursday, February 12, 2026 SUNNYVALE, Calif.--(BUSINESS WIRE)--JFrog Ltd. ("JFrog†) (Nasdaq: FROG), the Liquid Software company and creators of the JFrog Software Supply Chain Platform, today announced it will report financial results for the fourth quarter and fiscal 2025 on Thursday, February 12, 2026, following the market close. JFrog will host a conference call to discuss the results at 2:00 p.m. PT on the same day. Event: JFrog's Fourth Quarter and Fiscal 2025 Financial Results Conference Call ...
Safe & Green Holdings Corp. Adjourns 2025 Annual Meeting Due to Lack of Quorum
Globenewswire· 2026-01-14 21:04
Company Schedules Virtual Reconvening for Jan. 28, 2026; Proxy Solicitation to ContinueCONROE, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- via IBN - Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green” or the “Company”) announced today that its 2025 Annual Meeting of Stockholders, convened on Jan. 14, 2026, was adjourned after a quorum was not present in person or by proxy. As a result, no business was conducted at the meeting. The Company will reconvene the Annual Meeting virtually on Jan. 28, 2026, at ...
INVESTOR ALERT: Investigation of Travere Therapeutics, Inc. (TVTX) by Holzer & Holzer, LLC
Globenewswire· 2026-01-14 21:04
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Travere Therapeutics, Inc. (“Travere” or the “Company”) (NASDAQ: TVTX) complied with federal securities laws. On January 13, 2026, Travere disclosed that the U.S. Food and Drug Administration has extended the review timeline of its supplemental New Drug Application for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis. Following this news, the price of the Company’s stock dropped. If you purchased Travere sto ...
Exxon Mobil: A Solid Hold Even If Venezuela Is Uninvestable (NYSE:XOM)
Seeking Alpha· 2026-01-14 21:03
As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the extreme volatilities in BOTH the equity AND bond market.Join for a trial and see if our proven method can help you too. ...
AMZP: Why This 21% Yielding Amazon ETF Is Tops
Seeking Alpha· 2026-01-14 21:03
I am an Industrial Engineer by profession and have deep experience with a wide variety of financial instruments. I have tested various approaches over the years to shape an effective and sustainable investment approach. I believe in a long term investment horizon as oppose to shorter term trading and speculation. Everyone can build their investment objective around sustainable growth and income over the medium and long term. The best would be to invest as early as possible or simply manage your own investme ...
Exxon Mobil: A Solid Hold Even If Venezuela Is 'Uninvestable'
Seeking Alpha· 2026-01-14 21:03
As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy drawdowns despite the extreme volatilities in BOTH the equity AND bond market.Join for a trial and see if our proven method can help you too. ...